Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,745.60
(
0.10%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.18
(
0.71%
)
Bitcoin
71,137.95
(
1.77%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 89752

Friday, 01/29/2010 12:30:52 AM

Friday, January 29, 2010 12:30:52 AM

Post# of 257262
ACHN’s mention of the NS3 target in the latest PR may mean that ACH-2684 is a helicase inhibitor—or a combination helicase/protease inhibitor. If so, this is not a unique MoA; for instance, BMY’s BMS-650032 is such a compound.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today